Another Major DLL3 ADC Alliance As Hengrui Links With IDEAYA

Lung cancer
Chinese DLL3 ADCs nearly monopolize the class. • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Deals

More from Immuno-oncology